Population pharmacokinetics of cytarabine, etoposide, and daunorubicin in the treatment for acute myeloid leukemia

被引：0
|
作者：
Mikkel Krogh-Madsen
Brendan Bender
Morten Krogh Jensen
Ove Juul Nielsen
Lena E. Friberg
Per Hartvig Honoré
机构：
[1] University of Copenhagen,Department of Pharmacology and Pharmacotherapy, Faculty of Pharmaceutical Sciences
[2] Uppsala University,Department of Pharmaceutical Biosciences, Pharmacometrics Research Group
[3] Herlev Hospital,Department of Haematology L
[4] Rigshospitalet,124
来源：
Cancer Chemotherapy and Pharmacology | 2012年 / 69卷
关键词：
Cytarabine; Etoposide; Daunorubicin; Population pharmacokinetics; NONMEM; Acute myeloid leukemia;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1155 / 1163
页数：8
相关论文
共 50 条
  • [21] DAT (DAUNORUBICIN, CYTARABINE, 6-THIOGUANINE) IN ACUTE MYELOID-LEUKEMIA
    REES, JKH
    HAYHOE, FGJ
    [J]. LANCET, 1978, 1 (8078): : 1360 - 1361
  • [22] Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan
    Ikezoe, Takayuki
    Ando, Kiyoshi
    Onozawa, Masahiro
    Yamane, Takahisa
    Hosono, Naoko
    Morita, Yasuyoshi
    Kiguchi, Toru
    Iwasaki, Hiromi
    Miyamoto, Toshihiro
    Matsubara, Keisuke
    Sugimoto, Saori
    Miyazaki, Yasushi
    Kizaki, Masahiro
    Akashi, Koichi
    [J]. CANCER SCIENCE, 2022, 113 (12) : 4258 - 4266
  • [23] Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia
    Xu, WL
    Shen, HL
    Ao, ZF
    Chen, BA
    Xia, W
    Gao, F
    Zhang, YN
    [J]. LEUKEMIA RESEARCH, 2006, 30 (04) : 407 - 413
  • [24] Outpatient ADE (cytarabine, daunorubicin, and etoposide) is feasible and effective for the first relapse of pediatric acute myeloid leukemia: A prospective, phase II study
    Garg, Arun
    Ganguly, Shuvadeep
    Vishnubhatla, Sreenivas
    Chopra, Anita
    Bakhshi, Sameer
    [J]. PEDIATRIC BLOOD & CANCER, 2020, 67 (09)
  • [25] Resistance Mechanism of Acute Myeloid Leukemia Cells Against Daunorubicin and Cytarabine: A Literature Review
    Arwanih, Elly Y.
    Louisa, Melva
    Rinaldi, Ikhwan
    Wanandi, Septelia I.
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (12)
  • [26] SECONDARY ACUTE MYELOID LEUKEMIA - FIRST LINE TREATMENT WITH CYTARABINE, DAUNORUBICIN AND CYCLOSPORINE, A PORTUGUESE HOSPITAL'S EXPERIENCE
    Nunes, M.
    Leite, L.
    Chacim, S.
    Ferreira, C.
    Moreira, C.
    Pereira, D.
    Brito, M.
    Marques, M.
    Viterbo, L.
    Martins, A.
    Domingues, N.
    Moreira, I.
    Espirito-Santo, A.
    Oliveira, I.
    Mariz, J.
    [J]. HAEMATOLOGICA, 2013, 98 : 521 - 522
  • [27] Outpatient Administration of Liposomal Daunorubicin and Cytarabine (Vyxeos) in Patients With Secondary Acute Myeloid Leukemia
    Kasner, Margaret T.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (11) : 604 - 606
  • [28] Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule
    Lloyd E. Damon
    Laura J. Johnston
    Curt A. Ries
    Hope S. Rugo
    Delvyn Case
    Kenneth Ault
    Charles A. Linker
    [J]. Cancer Chemotherapy and Pharmacology, 2004, 53 : 468 - 474
  • [29] TREATMENT OF ACUTE MYELOID LEUKEMIA IN ADULTS WITH CYTARABINE AND THIOGUANINE
    FULLE, HH
    PRIBILLA, W
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1972, 97 (18) : 711 - +
  • [30] Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule
    Damon, LE
    Johnston, LJ
    Ries, CA
    Rugo, HS
    Case, D
    Ault, K
    Linker, CA
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (06) : 468 - 474
12345